Log in
/
Register
Home
Overview
Upload / Manage Data
Browse / Search Studies
Analyze Studies
Tutorials
FAQ
Data Repository
Overview
Upload / Manage Studies
Browse / Search Studies
Analyze Studies
Data Sharing Policy
Tutorials
FAQ
Databases
Overview
Metabolite Database
Human Metabolome Gene/Protein Database (MGP)
RefMet: Reference List of Metabolite Names
External Metabolomics Databases (Links)
Protocols
Overview
General Protocols
Study-specific Protocols
Tools
Overview
Load and analyze your own dataset
Analyze Studies
MS Searches
Structure drawing
REST Service
External Tools (Links)
About
Overview
Publishing Partners
How to Cite
How to Link
Terms of Use
Personnel
Contact
Sitemap
Search
Keyword Search
Advanced Searches
Return to study ST000046 main page
Show: (1)
HMDB and KEGG pathways
(2)
REACTOME pathways
containing these metabolites
Select
Metabolite Name
Metabolite Id
Refmet Name
Ret. Index
Quant. m/z
Analysis Display
Isoacitretin
ME649514
Isoacitretin
10.596096
-
MS negative ion mode/C18
Isoacitretin-10.753435
ME649515
Isoacitretin
10.753435
-
MS negative ion mode/C18
Isoacitretin-10.899509
ME649516
Isoacitretin
10.899509
-
MS negative ion mode/C18
Isoacitretin-14.103292
ME649517
Isoacitretin
14.103292
-
MS negative ion mode/C18
3D,7D,11D-Phytanicacid
ME649744
Phytanic acid
1.1209038
-
MS negative ion mode/HILIC
7-Dehydrologanintetraacetate
ME649791
7-Dehydrologanin tetraacetate
0.86618453
-
MS negative ion mode/HILIC
ABSCISICACID(cis,trans)
ME649804
Abscisic acid
1.1076537
-
MS negative ion mode/HILIC
Anhydrorhodovibrin
ME649828
Anhydrorhodovibrin
1.0739485
-
MS negative ion mode/HILIC
CucurbitacinB
ME649862
Cucurbitacin B
1.0716493
-
MS negative ion mode/HILIC
DEACETYLGEDUNIN
ME649869
Deacetylgedunin
1.0943528
-
MS negative ion mode/HILIC
GibberellinA9
ME649905
Gibberellin A9
1.9781137
-
MS negative ion mode/HILIC
Isoacitretin
ME649961
Isoacitretin
0.66905
-
MS negative ion mode/HILIC
Isoacitretin-0.9586385
ME649962
Isoacitretin
0.9586385
-
MS negative ion mode/HILIC
Isoacitretin-1.2870859
ME649963
Isoacitretin
1.2870859
-
MS negative ion mode/HILIC
Isoacitretin-1.4615195
ME649964
Isoacitretin
1.4615195
-
MS negative ion mode/HILIC
Isoacitretin-1.974581
ME649965
Isoacitretin
1.974581
-
MS negative ion mode/HILIC
Isoacitretin-2.0960872
ME649966
Isoacitretin
2.0960872
-
MS negative ion mode/HILIC
Isoacitretin-2.8331037
ME649967
Isoacitretin
2.8331037
-
MS negative ion mode/HILIC
Limonene-1,2-epoxide
ME649980
Limonene-1,2-epoxide
1.14834
-
MS negative ion mode/HILIC
Rhodovibrin
ME650063
Rhodovibrin
1.1201994
-
MS negative ion mode/HILIC
Spheroidene
ME650070
Spheroidene
1.071129
-
MS negative ion mode/HILIC
2-Methyl-5-isopropylhexa-2Z,5-dienal
ME648413
2-Methyl-5-isopropylhexa-2Z,5-dienal
1.0550998
-
MS positive ion mode/C18
3,4-Dihydrospirilloxanthin
ME648432
3,4-Dihydrospirilloxanthin
1.0482203
-
MS positive ion mode/C18
Dihydroxylycopene/OH-Rhodopin
ME648590
Dihydroxylycopene
0.97793657
-
MS positive ion mode/C18
OphiobolinA
ME648713
Ophiobolin A
5.376852
-
MS positive ion mode/C18
Parasiloxanthin/7,8-Dihydrozeaxanthin
ME648717
7,8-Dihydrozeaxanthin
1.0547636
-
MS positive ion mode/C18
Tiamulin
ME648765
Tiamulin
6.4403963
-
MS positive ion mode/C18
Tiamulin+6.5371113
ME648766
Tiamulin
6.5371113
-
MS positive ion mode/C18
2-Methyl-5-isopropylhexa-2Z,5-dienal
ME648894
2-Methyl-5-isopropylhexa-2Z,5-dienal
1.0550998
-
MS positive ion mode/HILIC
3,4-Dihydrospirilloxanthin
ME648913
3,4-Dihydrospirilloxanthin
1.0482203
-
MS positive ion mode/HILIC
Dihydroxylycopene/OH-Rhodopin
ME649072
Dihydroxylycopene
0.97793657
-
MS positive ion mode/HILIC
Loroxanthinester/Loroxanthindodecenoate
ME649167
Loroxanthin dodecenoate
5.119093
-
MS positive ion mode/HILIC
OphiobolinA
ME649209
Ophiobolin A
5.376852
-
MS positive ion mode/HILIC
Parasiloxanthin/7,8-Dihydrozeaxanthin
ME649213
7,8-Dihydrozeaxanthin
1.0547636
-
MS positive ion mode/HILIC
Tiamulin
ME649261
Tiamulin
6.4403963
-
MS positive ion mode/HILIC
Tiamulin+6.5371113
ME649262
Tiamulin
6.5371113
-
MS positive ion mode/HILIC
UCSD Metabolomics Workbench, a resource sponsored by the Common Fund of the National Institutes of Health
Terms of use
Site map
Contact
NMDR Personnel